HGF/c-Met signaling is a well-established oncogenic pathway: c-Met is amplified or overexpressed in multiple cancers (gastric, lung, renal, hepatocellular) HGF/c-Met activation promotes tumor cell proliferation, survival, invasion, and metastasis c-Met inhibitors are FDA-approved cancer drugs (cabozantinib, crizotinib, capmatinib) A compound that potentiates HGF/c-Met signaling raises theoretical concerns about promoting tumor growth or transformation with chronic use
GLP-1s, a natural and safer way We understand that GLP-1s seem to provide the answer to weight loss woes
GHK-Cu Side Effects Reported ghk-cu side effects in clinical settings are rare and typically mild
I went from 285 to 175 pounds
doi: 10.1007/s11695-021-05328-7 112
Although the evidence is as yet uncertain, weight loss associated with GLP-1 RAs in people without cancer may prevent obesity-related cancers